Emergent BioSolutions, Inc. (EBS)
11.41
+0.31
(+2.79%)
USD |
NYSE |
Jan 21, 12:42
Emergent BioSolutions Total Assets (Quarterly): 1.461B for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Boston Scientific Corp. | 42.71B |
| Eli Lilly & Co. | 114.94B |
| Penumbra, Inc. | 1.744B |
| Disc Medicine, Inc. | 630.46M |
| Black Diamond Therapeutics, Inc. | 157.73M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 878.50M |
| Shareholders Equity (Quarterly) | 582.50M |
| Debt to Equity Ratio | 1.152 |
| Current Ratio | 5.765 |
| Net Debt Paydown Yield | 8.86% |